Replies to post #113169 on Vivos Inc (RDGL)

[Drugdoctor]

Or... a PARTNERSHIP with FUNDING that would take the product through the HUMAN CLINICAL TRIALS and inject cash into the company complete with MILESTONE PAYMENTS! :-)

[Roofus]

This stock was $100 per share in 2007

Of course, the share structure only contained about 1/4 of the shares as it does now.
That would be equivalent to $25.00 per share with today's share structure.
It was able to get that high before without any FDA approval for isoPet.

Add in isoPet now, and human trials soon, and eventual FDA approval for humans (RadioGel), and who knows how high it can go.